BioMarin Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
10.08.26
/
50%
€56.96
Target price
10.08.27
€98.67
Performance (%)
2.21%
Price
14.08.26
€58.22
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr shows slight gains of 2.21%. This prediction currently runs until 10.08.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | 2.21% |
| iShares Core DAX® | 0.437% |
| iShares Nasdaq 100 | 1.057% |
| iShares Nikkei 225® | 1.769% |
| iShares S&P 500 | 0.368% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target raised by Canaccord Genuity Group Inc. from $111.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.24
22.05.26
22.05.26
€95.52
22.05.27
22.05.27
25.91%
14.08.26
14.08.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.78
26.02.26
26.02.26
€87.99
26.02.27
26.02.27
12.44%
14.08.26
14.08.26